0001140361-11-042084.txt : 20110815
0001140361-11-042084.hdr.sgml : 20110815
20110815164658
ACCESSION NUMBER: 0001140361-11-042084
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110630
FILED AS OF DATE: 20110815
DATE AS OF CHANGE: 20110815
EFFECTIVENESS DATE: 20110815
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayer Capital Management, LP
CENTRAL INDEX KEY: 0001471149
IRS NUMBER: 262134101
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1209
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-13640
FILM NUMBER: 111037177
BUSINESS ADDRESS:
STREET 1: 230 CALIFORNIA, SUITE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 4158744800
MAIL ADDRESS:
STREET 1: 230 CALIFORNIA, SUITE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
form13fhr.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: 6/30/2011
Check here if Amendment []; Amendment Number:
-------
This Amendment (Check only one.): [] is a restatement.
[] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Ayer Capital Management, LP
Address: 230 California Street, Suite 600
San Francisco, CA 94111
Form 13F File Number:
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this submission.
Persons Signing this Report on Behalf of Reporting Manager:
Name: Tom Glaser
Title: CFO
Phone: 415-874-4800
Signature, Place, and Date of Signing:
/s/ Tom Glaser San Francisco, CA 8/15/2011
--------------------------------- --------------------------------- ----------
[Signature] [City, State] [Date]
Report Type (Check only one):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
List of Other Managers Reporting for this Manager:
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 2
Form 13F Information Table Entry Total: 26
Form 13F Information Table Value Total: $ 132,379
--------------
(In Thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
No. Form 13F File Number Name
1 ACM Capital Partners, LLC
---- -------------------- ----------------------------------------------------
2 Jay Venkatesan
---- -------------------- ----------------------------------------------------
FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
---------------------------- -------------- --------- -------- ------------------ ---------- -------- ---------------------
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
---------------------------- -------------- --------- -------- --------- --- ---- ---------- -------- --------- ------ ----
ARTHROCARE CORP COM 043136100 13,095 391,257 SH DEFINED 1,2 391,257 0 0
BIOSPECIFICS TECHNOLOGIES COM 090931106 5,693 254,130 SH DEFINED 1,2 254,130 0 0
CELGENE CORP COM 151020104 9,545 158,237 SH DEFINED 1,2 158,237 0 0
CIGNA CORP COM 125509109 5,204 101,192 SH DEFINED 1,2 101,192 0 0
CELSION CORPORATION COM NEW 15117N305 5,276 1,565,706 SH DEFINED 1,2 1,565,706 0 0
CELL THERAPEUTICS INC COM NO PAR NEW 150934602 4,817 3,058,646 SH DEFINED 1,2 3,058,646 0 0
ENDOCYTE INC COM 29269A102 5,937 414,600 SH DEFINED 1,2 414,600 0 0
EXPRESS SCRIPTS INC COM 302182100 524 9,700 SH DEFINED 1,2 9,700 0 0
INTERMUNE INC COM 45884X103 2,859 79,762 SH DEFINED 1,2 79,762 0 0
INTERMUNE INC COM 45884X103 4,298 119,900 CALL DEFINED 1,2 119,900 0 0
KIPS BAY MED INC COM 49726K105 253 78,471 SH DEFINED 1,2 78,471 0 0
MEDIVATION INC COM 58501N901 5,784 269,900 CALL DEFINED 1,2 269,900 0 0
MCKESSON CORP COM 58155Q103 13,122 156,865 SH DEFINED 1,2 156,865 0 0
MEDCO HEALTH SOLUTIONS INC COM 58405U102 2,707 47,900 SH DEFINED 1,2 47,900 0 0
MERIT MED SYS INC COM 589889104 2,246 125,000 SH DEFINED 1,2 125,000 0 0
NPS PHARMACEUTICALS INC COM 62936P103 2,981 315,412 SH DEFINED 1,2 315,412 0 0
ONCOTHYREON INC COM 682324108 8,164 888,382 SH DEFINED 1,2 888,382 0 0
ONCOTHYREON INC COM 682324908 1,838 200,000 CALL DEFINED 1,2 200,000 0 0
PHARMATHENE INC COM 71714G902 588 200,000 CALL DEFINED 1,2 200,000 0 0
SCICLONE PHARMACEUTICALS INC COM 80862K104 1,856 307,215 SH DEFINED 1,2 307,215 0 0
SHANGPHARMA CORP-ADR SPONSORED ADR 81943P104 2,975 284,177 SH DEFINED 1,2 284,177 0 0
SPDR S&P 500 ETF TR COM 78462F953 13,197 100,000 PUT DEFINED 1,2 100,000 0 0
TARGACEPT INC COM 87611R306 2,107 100,000 SH DEFINED 1,2 100,000 0 0
THRESHOLD PHARMACEUTICALS COM NEW 885807206 2,036 1,219,394 SH DEFINED 1,2 1,219,394 0 0
UROPLASTY INC COM NEW 917277204 7,591 1,012,136 SH DEFINED 1,2 1,012,136 0 0
WELLPOINT INC COM 94973V107 7,686 97,576 SH DEFINED 1,2 97,576 0 0